1. Yamaguchi Y, Brenner M, Hearing VJ. The regulation of skin pigmentation. J Biol Chem 2007; 282: 27557-61.
2.
Brenner M, Hearing VJ. The protective role of melanin against UV damage in human skin. Photochem Photobiol 2008; 84: 539-49.
3.
Cichorek M, Wachulska M, Stasiewicz A, et al. Skin melanocytes: biology and development. Adv Dermatol Allergol 2013; 30: 30-41.
4.
Borovanský J, Riley PA. Physiological and pathological functions of melanosomes. In: Melanins and Melanosomes. Borovanský J, Riley PA, editors. Wiley-Blackwell, Weinheim, Germany 2011; 343-81.
5.
Park HY, Kosmadaki M, Yaar M, et al. Cellular mechanisms regulating human melanogenesis. Cell Mol Life Sci 2009; 66: 1493-506.
6.
Bae-Harboe YSC, Park HY. Tyrosinase: a central regulatory protein for cutaneous pigmentation. J Invest Dermatol 2012; 132: 2678-80.
7.
Ito S, Wakamatsu K. Chemistry of mixed melanogenesis-pivotal roles of dopaquinone. Patochem Photobiol 2008; 84: 582-92.
8.
Simon JD, Peles D, Wakamatsu K, et al. Current challenges in understanding melanogenesis: bridging chemistry, biological control, morphology, and function. Pigment Cell Melanoma Res 2009; 22: 563-79.
9.
Kondo T, Hearing VJ. Update on the regulation of mammalian melanocyte function and skin pigmentation. Expert Rev Dermatol 2011; 6: 97-108.
10.
Aoki H, Moro O. Involvement of microphthalmia-associated transcription factor (MITF) in expression of human melanocortin-1 receptor (MC1R). Life Sci 2002; 71: 2171-9.
11.
Vachtenheim J, Borovanský J. “Transcription physiology” of pigment formation in melanocytes: central role of MITF. Exp Dermatol 2010; 19: 617-27.
12.
Slominski A, Wortsman J. Neuroendocrinology of the skin. Endocr Rev 2000; 21: 457-87.
13.
Abdel-Malek ZA, Swope VB. Epidermal melanocytes: regulation of their survival, proliferation, and function in human skin. In: Melanoma Development: Molecular Biology, Genetics and Clinical Application. Bosserhoff A (ed.). Springer, Vienna, Austria 2011; 7-33.
14.
Wegner M. All-purpose Sox: the many roles of Sox proteins in gene expression. Int J Biochem Cell Biol 2010; 42: 381-90.
15.
Kubic JD, Young KP, Plummer RS, et al. Pigmentation PAX‐ways: the role of Pax3 in melanogenesis, melanocyte stem cell maintenance, and disease. Pigment Cell Melanoma Res 2008; 21: 627-45.
16.
Solano F. Melanins: skin pigments and much more – types, structural models, biological functions, and formation routes. New J Sci 2014; 2014: 1-28.
17.
Takeuchi S, Zhang W, Wakamatsu K, et al. Melanin acts as a potent UVB photosensitizer to cause an atypical mode of cell death in murine skin. Proc Natl Acad Sci USA 2004; 101: 15076-81.
18.
Mariano A, Bigioni I, Scotto d’Abusco A, et al. Pheomelanin effect on UVB radiation-induced oxidation/nitration of l-tyrosine. Int J Mol Sci 2021; 23: 267.
19.
Nasti TH, Timares L. MC1R, eumelanin and pheomelanin: their role in determining the susceptibility to skin cancer. Photochem Photobiol 2015; 91: 188-200.
20.
Srivastava MK, Sinha P, Clements VK, et al. Myeloid-derived suppressor cells inhibit T-cell activation by depleting cystine and cysteine. Cancer Res 2010; 70: 68-77.
21.
Kusmartsev S, Nefedova Y, Yoder D, et al. Antigen-specific inhibition of CD8+ T cell response by immature myeloid cells in cancer is mediated by reactive oxygen species. J Immunol 2004; 172: 989-99.
22.
Riley PA. Melanogenesis and melanoma. Pigment Cell Res 2003; 16: 548-52.
23.
Morgan AM, Lo J, Fisher DE. How does pheomelanin synthesis contribute to melanomagenesis? Two distinct mechanisms could explain the carcinogenicity of pheomelanin synthesis. BioEssays 2013; 35: 672-6.
24.
Ranadive NS, Shirwadkar S, Persad S, et al. Effects of melanin-induced free radicals on the isolated rat peritoneal mast cells. J Invest Dermatol 1986; 86: 303-7.
25.
Galván I, Inácio Â, Romero‐Haro AA, et al. Adaptive downregulation of pheomelanin‐related Slc7a11 gene expression by environmentally induced oxidative stress. Mol Ecol 2017; 26: 849-58.
26.
Premi S. Role of melanin chemiexcitation in melanoma progression and drug resistance. Front Oncol 2020; 10: 1305.
27.
Premi S, Wallisch S, Mano CM, et al. Chemiexcitation of melanin derivatives induces DNA photoproducts long after UV exposure. Science 2015; 347: 842-7.
28.
Boyle JL, Haupt HM, Stern JB, et al. Tyrosinase expression in malignant melanoma, desmoplastic melanoma, and peripheral nerve tumors. Arch Pathol Lab Med 2002; 126: 816-22.
29.
Stevens GL, Scheer WD, Levine EA. Detection of tyrosinase mRNA from the blood of melanoma patients. Cancer Epidemiol Biomarkers Prev 1996; 5: 293-6.
30.
Wakamatsu K, Fukushima S, Minagawa A, et al. Significance of 5-S-cysteinyldopa as a marker for melanoma. Int J Mol Sci 2020; 21: 432.
31.
Kobayashi T, Hearing VJ. Direct interaction of tyrosinase with Tyrp1 to form heterodimeric complexes in vivo. J Cell Sci 2007; 120: 4261-8.
32.
Slominski RM, Sarna T, P³onka PM, et al. Melanoma, melanin, and melanogenesis: the Yin and Yang rRelationship. Front Oncol 2022; 12: 842496.
33.
Snyman M, Walsdorf RE, Wix SN, et al. The metabolism of melanin synthesis – from melanocytes to melanoma. Pigment Cell Melanoma Res 2024; 37: 438-52.
34.
Costin GE, Hearing VJ. Human skin pigmentation: melanocytes modulate skin color in response to stress. FASEB J 2007; 21: 976-94.
35.
Aberdam E, Bertolotto C, Sviderskaya EV, et al. Involvement of microphthalmia in the inhibition of melanocyte lineage differentiation and of melanogenesis by agouti signal protein. J Biol Chem 1998; 273: 19560-5.
36.
Vachtenheim J, Novotna H, Ghanem G. Transcriptional repression of the microphthalmia gene in melanoma cells correlates with the unresponsiveness of target genes to ectopic microphthalmia-associated transcription factor. J Invest Dermatol 2001; 117: 1505-11.
37.
Harno E, Gali Ramamoorthy T, Coll AP, et al. POMC: the physiological power of hormone processing. Physiol Rev 2018; 98: 2381-430.
38.
Wakamatsu K, Zippin JH, Ito S. Chemical and biochemical control of skin pigmentation with special emphasis on mixed melanogenesis. Pigment Cell Melanoma Res 2021; 34: 730-47.
39.
Chiaverini C, Sillard L, Flori E, et al. Cystinosin is a melanosomal protein that regulates melanin synthesis. FASEB J 2012; 26: 3779-89.
40.
Koppula P, Zhang Y, Zhuang L, et al. Amino acid transporter SLC7A11/xCT at the crossroads of regulating redox homeostasis and nutrient dependency of cancer. Cancer Commun 2018; 38: 12.
41.
Ohbayashi N, Fukuda M. Recent advances in understanding the molecular basis of melanogenesis in melanocytes. F1000 Res 2020; 9: F1000 Faculty Rev-608.
42.
Ibarrola-Villava M, Fernandez LP, Alonso S, et al. A customized pigmentation SNP array identifies a novel SNP associated with melanoma predisposition in the SLC45A2 gene. PLoS One 2011; 6: e19271.
43.
Park J, Talukder AH, Lim SA, et al. SLC45A2: a melanoma antigen with high tumor selectivity and reduced potential for autoimmune toxicity. Cancer Immunol Res 2017; 5: 618-29.
44.
Liu Y, Chi W, Tao L, et al. Ablation of proton/glucose exporter SLC45A2 enhances melanosomal glycolysis to inhibit melanin biosynthesis and promote melanoma metastasis. J Invest Dermatol 2022; 142: 2744-55.e9.
45.
Liu J, Fukunaga-Kalabis M, Li L, et al. Developmental pathways activated in melanocytes and melanoma. Arch Biochem Biophys 2014; 563: 13-21.
46.
Ito S, Miyake S, Maruyama S, et al. Acid hydrolysis reveals a low but constant level of pheomelanin in human black to brown hair, Pigment Cell Melanoma Res 2018; 31: 393-403.
47.
Kurkiewicz S, Marek £, Tam I, et al. A simple method to determine pheomelanin content and structure in FFPE human melanoma specimens. Processes 2025; 13: 1636.
48.
Dzier¿êga-Lêcznar A, Kurkiewicz S, Tam I, et al. Pheomelanin content of cultured human melanocytes from lightly and darkly pigmented skin: a pyrolysis-gas chromatography/tandem mass spectrometry study. JAAP 2017; 124: 349-54.
49.
Christensen JN, Schmidt H, Steiniche T, et al. Identification of robust reference genes for studies of gene expression in FFPE melanoma samples and melanoma cell lines. Melanoma Res 2020; 30: 26-38.
50.
Adler M, White C. Amelanotic malignant melanoma. Semin Cutan Med Surg 1997; 16: 122-30.
51.
Cheung WL, Patel RR, Leonard A, et al. Amelanotic melanoma: a detailed morphologic analysis with clinicopathologic correlation of 75 cases. J Cutan Pathol 2012; 39: 33-9.
52.
Wang H, Osseiran S, Igras V, et al. In vivo coherent Raman imaging of the melanomagenesis-associated pigment pheomelanin. Sci Rep 2016; 6: 37986.
53.
Lee Y, Gunduz E, Tamamura R, et al. Characteristics of melanosomes in melanotic and amelanotic melanomas. J Hard Tissue Biol 2004; 13: 87-90.
54.
Ito S, Jimbow K. Quantitative analysis of eumelanin and pheomelanin in hair and melanomas. J Invest Dermatol 1983; 80: 268-72.
55.
Hu DN, Wakamatsu K, Ito S, et al. Comparison of eumelanin and pheomelanin content between cultured uveal melanoma cells and normal uveal melanocytes. Melanoma Res 2009; 19: 75-9.
56.
Wang J, Yang J. Identification of significant genes with a poor prognosis in skin cutaneous malignant melanoma based on a bioinformatics analysis. Ann Transl Med 2022; 10: 448-8.
57.
Ainger SA, Yong XL, Wong SS, et al. DCT protects human melanocytic cells from UVR and ROS damage and increases cell viability. Exp Dermatol 2014; 23: 916-21.
58.
Roider E, Lakatos AIT, McConnell AM, et al. MITF regulates IDH1, NNT, and a transcriptional program protecting melanoma from reactive oxygen species. Sci Rep 2024; 14: 21527.
59.
Dankort D, Curley DP, Cartlidge RA, et al. BrafV600E cooperates with Pten loss to induce metastatic melanoma. Nat Genet 2009; 41: 544-52.
60.
Laurette P, Coassolo S, Davidson G, et al. Chromatin remodellers Brg1 and Bptf are required for normal gene expression and progression of oncogenic Braf-driven mouse melanoma. Cell Death Differ 2020; 27: 29-43.
61.
Li P, Yu J, Huang F, et al. SLC7A11-associated ferroptosis in acute injury diseases: mechanisms and strategies. Eur Rev Med Pharmacol Sci 2023; 27: 4386-98.
62.
Galván I, Inácio Â, Dañino M, et al. High SLC7A11 expression in normal skin of melanoma patients. Cancer Epidemiol 2019; 62: 101582.
63.
Le L, Escobar IE, Ho T, et al. SLC45A2 protein stability and regulation of melanosome pH determine melanocyte pigmentation. MBoC 2020; 31: 2687-702.
64.
Hopkins ZH, Carlisle RP, Frost ZE, et al. Risk factors and predictors of survival among patients with amelanotic melanoma compared to melanotic melanoma in the national cancer database. J Clin Aesthet Dermatol 2021; 14: 36-43.
65.
Bin BH, Bhin J, Yang SH, et al. Membrane-associated transporter protein (MATP) regulates melanosomal pH and influences tyrosinase activity. PLoS One 2015; 10: e0129273.
66.
Ito S, Wakamatsu K. Human hair melanins: what we have learned and have not learned from mouse coat color pigmentation. Pigment Cell Melanoma Res 2011; 24: 63-74.
67.
Hu S, Chen Y, Zhao B, et al. KIT is involved in melanocyte proliferation, apoptosis and melanogenesis in the rex rabbit. Rabbit Peer J 2020; 8: e9402.
68.
Guo W, Wang H, Li C. Signal pathways of melanoma and targeted therapy. Signal Transduct Target Ther 2021; 6: 424.
69.
Pu Y, Lei M, Chen Y, et al. Hey1 promotes migration and invasion of melanoma cells via GRB2/PI3K/AKT signaling cascade. J Cancer 2021; 12: 6979-88.
70.
Robertson GP. Functional and therapeutic significance of Akt deregulation in malignant melanoma. Cancer Metastasis Rev 2005; 24: 273-85.
71.
Gagliardi PA, Puliafito A, Primo L. PDK1: at the crossroad of cancer signaling pathways. Semin Cancer Biol 2018; 48: 27-35.
72.
Kim GH, Fang XQ, Lim WJ, et al. Cinobufagin suppresses melanoma cell growth by inhibiting LEF1. Int J Mol Sci 2020; 21: 6706.
